Shruti Sharma Selected Research

Peptides (Polypeptides)

1/2023	Silver-Nanoparticle-Embedded Short Amphiphilic Peptide Nanostructures and Their Plausible Application to Reduce Bacterial Infections.
10/2021	Intra-population differences of apolipoproteins in the aqueous humor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shruti Sharma Research Topics

Disease

24	Neoplasms (Cancer) 01/2024 - 11/2012
16	Bites and Stings (Sting) 04/2024 - 11/2010
13	Mitochondrial Diseases (Mitochondrial Disease) 12/2023 - 01/2008
12	Inflammation (Inflammations) 02/2023 - 07/2009
10	Infections 10/2020 - 05/2010
9	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2023 - 01/2015
9	Pulmonary Hypertension 01/2016 - 10/2007
6	Congenital Heart Defects (Congenital Heart Defect) 10/2017 - 11/2009
4	Carcinoma (Carcinomatosis) 12/2023 - 01/2019
4	Arthritis (Polyarthritis) 01/2023 - 02/2015
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 08/2019
4	Acute Lung Injury 01/2017 - 05/2010
3	Adenocarcinoma 03/2024 - 11/2021
3	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 01/2019
3	Disease Progression 09/2023 - 10/2016
3	Glaucoma 02/2023 - 03/2021
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 02/2015
3	Leukemia 03/2018 - 10/2016
3	Hypoxia (Hypoxemia) 06/2014 - 03/2007
2	Cataract (Cataracts) 04/2024 - 09/2023
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 09/2023 - 10/2021
2	Breast Neoplasms (Breast Cancer) 02/2023 - 01/2021
2	Residual Neoplasm 01/2022 - 01/2021
2	Atrial Fibrillation 12/2020 - 04/2020
2	Ischemia 09/2019 - 03/2007
2	Colonic Neoplasms (Colon Cancer) 04/2018 - 10/2016
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2017 - 10/2016
2	Peritonitis 01/2017 - 02/2015
2	Splenomegaly 02/2016 - 07/2015
2	Hypertrophy 02/2015 - 03/2013
2	Vascular Remodeling 07/2013 - 03/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2010 - 01/2009
2	Rheumatoid Arthritis 10/2009 - 12/2008
1	AIDS-Related Complex (ARC) 04/2024
1	Hepatomegaly 03/2024
1	Cicatrix (Scar) 06/2023
1	Macular Edema 02/2023
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 02/2023
1	Keratitis 02/2023
1	Dry Eye Syndromes (Dry Eye Syndrome) 02/2023
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023

Drug/Important Bio-Agent (IBA)

16	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 11/2010
14	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2012
9	Carnitine (L-Carnitine)FDA LinkGeneric 10/2017 - 01/2008
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2017 - 03/2007
8	Circulating Tumor DNAIBA 12/2023 - 01/2021
8	Interleukin-6 (Interleukin 6)IBA 12/2023 - 01/2019
7	CytokinesIBA 04/2024 - 08/2011
7	RNA (Ribonucleic Acid)IBA 12/2023 - 07/2015
7	Biomarkers (Surrogate Marker)IBA 09/2023 - 04/2018
6	InterferonsIBA 04/2024 - 11/2012
5	Interferon Type IIBA 04/2024 - 08/2011
5	atezolizumabIBA 03/2024 - 01/2021
5	AutoantibodiesIBA 01/2021 - 02/2015
5	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017 - 10/2007
5	Superoxides (Superoxide)IBA 10/2017 - 10/2007
4	Retinaldehyde (Retinal)IBA 12/2023 - 01/2019
4	LigandsIBA 11/2023 - 02/2015
4	ibrutinibIBA 12/2018 - 10/2016
4	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2017 - 06/2008
3	AntigensIBA 12/2022 - 12/2019
3	Pyruvic Acid (Pyruvate)IBA 10/2017 - 01/2008
3	Lactic Acid (Lactate)FDA LinkGeneric 10/2017 - 01/2008
3	deoxyribonuclease II (DNASE II)IBA 02/2017 - 02/2015
3	LipopolysaccharidesIBA 01/2017 - 01/2012
3	Phosphotransferases (Kinase)IBA 10/2016 - 08/2011
3	Nucleic AcidsIBA 02/2016 - 02/2015
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2013 - 07/2012
3	Adenosine Triphosphate (ATP)IBA 01/2012 - 06/2008
2	Glutathione (Reduced Glutathione)IBA 04/2024 - 01/2012
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 04/2024 - 01/2023
2	Peptides (Polypeptides)IBA 01/2023 - 10/2021
2	Hormones (Hormone)IBA 10/2021 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2019 - 03/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 02/2015
2	AntioxidantsIBA 07/2013 - 10/2007
2	vadimezanIBA 05/2013 - 11/2012
2	Arginine (L-Arginine)FDA Link 05/2013 - 11/2009
2	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2013 - 07/2010
2	Methotrexate (Mexate)FDA LinkGeneric 10/2009 - 12/2008
1	Ligases (Synthetase)IBA 04/2024
1	Glutamic Acid (Glutamate)FDA Link 04/2024
1	Aspartic Acid (Aspartate)FDA Link 04/2024
1	Triglycerides (Triacylglycerol)IBA 03/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024
1	Docetaxel (Taxotere)FDA Link 01/2024
1	Capecitabine (Xeloda)FDA Link 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 11/2023
1	chemotactic factor inactivatorIBA 09/2023
1	Complement System Proteins (Complement)IBA 09/2023
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 09/2023
1	AntibodiesIBA 06/2023
1	MicroRNAs (MicroRNA)IBA 02/2023

Therapy/Procedure

19	Therapeutics 12/2022 - 05/2013
5	Drug Therapy (Chemotherapy) 03/2024 - 01/2021
3	Immunotherapy 01/2024 - 01/2021
2	Adjuvant Chemotherapy 01/2023 - 08/2019
2	Hand Hygiene 05/2019 - 07/2011
1	Neoadjuvant Therapy 01/2024